Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ VGAT Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA14701
Description
This antibody is predicted to react with bovine, canine and non-human primate based on 100% sequence homology. In Western blot, this antibody is specific for the ~53 kDa VGAT protein.
The Vesicular GABA Amino Acid Transporter (VGAT) is responsible for transport of the inhibitory neurotransmitter into synaptic vesicles (McIntire et al., 1997). The VGAT protein (also known as the Vesicular Inhibitory Amino Aid Transporter or VIAAT) is expressed in synaptic vesicles of both glycine and GABAergic synapses throughout the CNS (Chaudhry et al., 1998). Expression of the VGAT protein changes during development and also in response to patterns of neuronal activity (De et al., 2005).
Specifications
VGAT | |
Polyclonal | |
0.01M HEPES with 100 μg/mL BSA, 50% glycerol, 0.15M NaCl and no preservative; pH 7.5 | |
O35458, O35633 | |
SLC32A1 | |
Synthetic peptide corresponding to the N-terminal region of rat SLC32A1 conjugated to KLH. | |
100 μL | |
Primary | |
Mouse, Rat, Chicken, Frog | |
Antibody | |
IgG |
Immunohistochemistry, Western Blot, Immunocytochemistry | |
Unconjugated | |
SLC32A1 | |
GABA and glycine transporter; GVAT; hVIAAT; mVGAT; mVIAAT; R75019; rGVAT; SLC32A1; solute carrier family 32 (GABA vesicular transporter), member 1; solute carrier family 32 member 1; vasicular inhibitory amino acid transporter 10D; vesicular GABA transporter; Vesicular inhibitory amino acid transporter; Vgat; Viaat | |
Rabbit | |
Affinity Chromatography | |
RUO | |
22348, 419167, 83612 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Safety and Handling
WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction